Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BY-NC-ND 4.0Nature Communications

Single-cell landscape of human adipose tissue reveals THBS1 as a potential driver of fibro-inflammation in metabolic disease

3 more authors

Abstract

The cellular complexity of adipose tissue plays a critical role in the pathogenesis of metabolic disease; however, mechanisms underlying adipose dysfunction remain poorly understood. Here, we constructed a single-nucleus and bulk transcriptomic atlas of human visceral adipose tissues from an ethnically homogeneous cohort with defined metabolic states: lean with normal glucose tolerance, obesity, and obesity with type 2 diabetes. Single-nucleus RNA sequencing (snRNA-seq) revealed a fibro-inflammatory subpopulation of adipose stem cells and adipocytes characterized by high THBS1 expression, which were enriched in individuals with obesity and obesity with type 2 diabetes compared to lean controls. Through complementary in vitro (human primary ASCs, THP-1 macrophages, and Matrigel-captured mature adipocytes), ex vivo (mouse and human visceral adipose tissue explants), and in vivo (gain-of-function and antibody-mediated neutralization) experiments, we demonstrated that THBS1 promoted adipose fibrosis and inflammation via macrophage-mediated TGFβ activation, impairing adipogenesis and adipocyte function. Inhibition of THBS1 attenuated fibro-inflammatory features in metabolically dysfunctional adipose tissues. Moreover, THBS1 levels in plasma and adipocytes correlated with metabolic traits, including BMI and HbA1c. Collectively, our study provides a cellular atlas of human visceral adipose tissues across metabolic disease states and identifies THBS1 as a key pathogenic driver and potential therapeutic target.

Related

  1. Single-nucleus analysis of human white adipose tissue reveals adipocyte subsets with distinct metabolic profiles
    Vissarion Efthymiou, Adhideb Ghosh, Sean Kodani +17
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textProteomics & metabolomicsGeneral biologyHAL
  2. Micro-fragmented adipose tissue reprogrammes the systemic molecular landscape of inflammatory knee osteoarthritis
    D. Primorac, V. Molnar, P. Brlek +7
    medRxivPreprintAll rights reservedFull textHuman geneticsmedRxiv
  3. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice
    Noriaki Kawanishi, Hiromi Yano, Yuka Yokogawa +1
    PubMedPeer-reviewedLicence not stated456 citedEndocrinology & metabolismEpidemiology & public healthOpenAlex
  4. Obesity, Metabolic Modulation, and Arrhythmias: From Adipose Tissue Dysfunction to a Modifiable Arrhythmogenic Substrate
    Margherita Tiezzi, Federica Valli, Andrea Mengozzi +5
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Prometheus’s Fire, Part II: The Hydra of Inflammation—Multiorgan Self-Amplifying Inflammatory Loops in Obesity: Molecular Crosstalk Between Adipose Tissue, Liver, Skeletal Muscle, Pancreas and Cardiovascular System
    Anna Grudniewska, Beata Mrozikiewicz-Rakowska, Kacper Wiszniewski +2
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
BibTeX
@article{jung2026singlecell,
  title = {{Single-cell landscape of human adipose tissue reveals THBS1 as a potential driver of fibro-inflammation in metabolic disease}},
  author = {Jisu Jung and Eun Seo Park and Na Keum Lee and Jung-Jae Lee and Uijin Juang and Qingzhi Huang and Young Suk Park and Hyung Joon Kim and Jung-Kwon Kim and Tae Jung Oh and Jae Myoung Suh and Jae Bum Kim and Joon Ho Moon and Jong Kyoung Kim and Sung Hee Choi},
  journal = {Nature Communications},
  year = {2026},
  month = oct,
  doi = {10.1038/s41467-026-77107-w},
  url = {https://www.nature.com/articles/s41467-026-77107-w},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Single-cell landscape of human adipose tissue reveals THBS1 as a potential driver of fibro-inflammation in metabolic disease
AU  - Jisu Jung
AU  - Eun Seo Park
AU  - Na Keum Lee
AU  - Jung-Jae Lee
AU  - Uijin Juang
AU  - Qingzhi Huang
AU  - Young Suk Park
AU  - Hyung Joon Kim
AU  - Jung-Kwon Kim
AU  - Tae Jung Oh
AU  - Jae Myoung Suh
AU  - Jae Bum Kim
AU  - Joon Ho Moon
AU  - Jong Kyoung Kim
AU  - Sung Hee Choi
PY  - 2026
DA  - 2026/10/27
JO  - Nature Communications
DO  - 10.1038/s41467-026-77107-w
UR  - https://www.nature.com/articles/s41467-026-77107-w
AB  - The cellular complexity of adipose tissue plays a critical role in the pathogenesis of metabolic disease; however, mechanisms underlying adipose dysfunction remain poorly understood. Here, we constructed a single-nucleus and bulk transcriptomic atlas of human visceral adipose tissues from an ethnically homogeneous cohort with defined metabolic states: lean with normal glucose tolerance, obesity, and obesity with type 2 diabetes. Single-nucleus RNA sequencing (snRNA-seq) revealed a fibro-inflammatory subpopulation of adipose stem cells and adipocytes characterized by high THBS1 expression, which were enriched in individuals with obesity and obesity with type 2 diabetes compared to lean controls. Through complementary in vitro (human primary ASCs, THP-1 macrophages, and Matrigel-captured mature adipocytes), ex vivo (mouse and human visceral adipose tissue explants), and in vivo (gain-of-function and antibody-mediated neutralization) experiments, we demonstrated that THBS1 promoted adipose fibrosis and inflammation via macrophage-mediated TGFβ activation, impairing adipogenesis and adipocyte function. Inhibition of THBS1 attenuated fibro-inflammatory features in metabolically dysfunctional adipose tissues. Moreover, THBS1 levels in plasma and adipocytes correlated with metabolic traits, including BMI and HbA1c. Collectively, our study provides a cellular atlas of human visceral adipose tissues across metabolic disease states and identifies THBS1 as a key pathogenic driver and potential therapeutic target.
SN  - 2041-1723
ER  -